06/29/2026 | Press release | Distributed by Public on 06/29/2026 13:35
| Fund | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
| BNY Mellon Dynamic Value ETF | $32 | 0.60%* |
| * |
Annualized.
|
|
Fund Size (Millions) |
Number of Holdings |
Portfolio Turnover |
| $1,375 | 83 | 58.99% |
| Fund | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
| BNY Mellon Concentrated Growth ETF | $25 | 0.50%* |
| * |
Annualized.
|
|
Fund Size (Millions) |
Number of Holdings |
Portfolio Turnover |
| $119 | 29 | 5.97% |
Item 1. Reports to Stockholders (cont.).
| (b) | Not applicable. |
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
| (a) | The Schedule of Investments in securities of unaffiliated issuers as of the close of the Reporting Period is included in the financial statements filed under Item 7 of this Form N-CSR. |
| (b) | Not applicable. |
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
The following is a copy of the Registrant's most recent financial statements and financial highlights.
|
Item 7. Financial Statements and Financial Highlights for Open-End Management
Investment Companies
|
3
|
|
Schedule of Investments
|
3
|
|
Statement of Assets and Liabilities
|
5
|
|
Statement of Operations
|
6
|
|
Statement of Changes in Net Assets
|
7
|
|
Financial Highlights
|
9
|
|
Notes to Financial Statements
|
10
|
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management
Investment Companies
|
16
|
|
Item 9. Proxy Disclosures for Open-End Management Investment Companies
|
17
|
|
Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End
Management Investment Companies
|
18
|
|
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts
|
19
|
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Equity Securities - Common Stocks - 96.7%
|
|||||
|
Capital Goods - 8.9%
|
|||||
|
BAE Systems PLC, ADR
|
33,883
|
3,783,376
|
|||
|
Deere & Co.
|
4,797
|
2,829,606
|
|||
|
Eaton Corp. PLC
|
9,074
|
3,929,133
|
|||
|
|
10,542,115
|
||||
|
Consumer Discretionary Distribution & Retail - 10.3%
|
|||||
|
Amazon.com, Inc.(a)
|
36,291
|
9,619,293
|
|||
|
The Home Depot, Inc.
|
7,760
|
2,551,488
|
|||
|
|
12,170,781
|
||||
|
Consumer Durables & Apparel - .9%
|
|||||
|
LVMH Moet Hennessy Louis Vuitton SE, ADR(b)
|
10,355
|
1,098,769
|
|||
|
Financial Services - 16.7%
|
|||||
|
BlackRock, Inc.
|
3,464
|
3,691,238
|
|||
|
Blackstone, Inc.
|
29,275
|
3,676,355
|
|||
|
Intercontinental Exchange, Inc.
|
16,856
|
2,664,765
|
|||
|
Mastercard, Inc., Cl. A
|
8,666
|
4,358,305
|
|||
|
S&P Global, Inc.
|
4,022
|
1,734,407
|
|||
|
Visa, Inc., Cl. A(b)
|
11,148
|
3,677,056
|
|||
|
|
19,802,126
|
||||
|
Food, Beverage & Tobacco - 2.8%
|
|||||
|
Philip Morris International, Inc.
|
20,357
|
3,360,330
|
|||
|
Insurance - 2.2%
|
|||||
|
The Progressive Corp.
|
12,845
|
2,585,442
|
|||
|
Media & Entertainment - 12.4%
|
|||||
|
Alphabet, Inc., Cl. C
|
26,321
|
10,053,043
|
|||
|
Meta Platforms, Inc., Cl. A
|
7,612
|
4,657,859
|
|||
|
|
14,710,902
|
||||
|
Pharmaceuticals, Biotechnology & Life Sciences - 6.0%
|
|||||
|
AstraZeneca PLC
|
13,953
|
2,614,373
|
|||
|
Eli Lilly & Co.
|
4,808
|
4,493,557
|
|||
|
|
7,107,930
|
||||
|
Semiconductors & Semiconductor Equipment - 22.9%
|
|||||
|
ASML Holding NV
|
2,772
|
3,988,880
|
|||
|
Broadcom, Inc.
|
8,910
|
3,719,301
|
|||
|
NVIDIA Corp.
|
58,773
|
11,729,328
|
|||
|
Taiwan Semiconductor Manufacturing Co. Ltd., ADR
|
9,989
|
3,956,243
|
|||
|
Texas Instruments, Inc.
|
13,382
|
3,761,413
|
|||
|
|
27,155,165
|
||||
|
Software & Services - 8.9%
|
|||||
|
Intuit, Inc.
|
6,439
|
2,501,551
|
|||
|
Microsoft Corp.
|
16,706
|
6,812,373
|
|||
|
ServiceNow, Inc.(a)
|
14,326
|
1,265,129
|
|||
|
|
10,579,053
|
||||
|
Technology Hardware & Equipment - 4.7%
|
|||||
|
Apple, Inc.
|
20,455
|
5,550,464
|
|||
|
Total Equity Securities - Common Stocks
(cost $59,451,385)
|
114,663,077
|
||||
|
Description
|
|
1-Day
Yield (%)
|
|
Shares
|
Value ($)
|
|
Investment Companies - 3.3%
|
|||||
|
Registered Investment Companies - 3.3%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(c)
(cost $3,853,934)
|
3.61
|
3,853,934
|
3,853,934
|
||
|
Investment of Cash Collateral for Securities Loaned - .2%
|
|||||
|
Registered Investment Companies - .2%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(c)
(cost $287,550)
|
3.61
|
287,550
|
287,550
|
||
|
Total Investments (cost $63,592,869)
|
|
100.2%
|
118,804,561
|
||
|
Liabilities, Less Cash and Receivables
|
|
(.2%)
|
(183,236)
|
||
|
Net Assets
|
100.0%
|
118,621,325
|
|||
|
ADR-American Depositary Receipt
|
|
(a)
|
Non-income producing security.
|
|
(b)
|
Security, or portion thereof, on loan. At April 30, 2026, the value of the fund's securities on loan was $3,926,611 and the value of the collateral was
$4,059,231, consisting of cash collateral of $287,550 and U.S. Government & Agency securities valued at $3,771,681. In addition, the value of collateral
may include pending sales that are also on loan.
|
|
(c)
|
Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's
prospectus.
|
|
Affiliated Issuers
|
|||||
|
Description
|
Value ($)
10/31/2025
|
Purchases ($)†
|
Sales ($)
|
Value ($)
4/30/2026
|
Dividends/
Distributions ($)
|
|
Registered Investment Companies - 3.3%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market
Fund, Institutional Shares - 3.3%
|
4,442,801
|
741,968
|
(1,330,835)
|
3,853,934
|
81,288
|
|
Investment of Cash Collateral for Securities Loaned - .2%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market
Fund, Institutional Shares - .2%
|
-
|
4,749,070
|
(4,461,520)
|
287,550
|
44,707††
|
|
Total - 3.5%
|
4,442,801
|
5,491,038
|
(5,792,355)
|
4,141,484
|
125,995
|
|
†
|
Includes reinvested dividends/distributions.
|
|
††
|
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and
other payments to and from borrowers of securities.
|
|
|
Cost
|
Value
|
|
Assets ($):
|
||
|
Investments in securities-See Schedule of Investments
(including securities on loan, valued at $3,926,611)-Note 2(c):
|
||
|
Unaffiliated issuers
|
59,451,385
|
114,663,077
|
|
Affiliated issuers
|
4,141,484
|
4,141,484
|
|
Dividends and securities lending income receivable
|
96,470
|
|
|
Tax reclaim receivable-Note 2(b)
|
55,150
|
|
|
|
118,956,181
|
|
|
Liabilities ($):
|
||
|
Due to BNY Mellon ETF Investment Adviser, LLC-Note 3(b)
|
47,306
|
|
|
Liability for securities on loan-Note 2(c)
|
287,550
|
|
|
|
334,856
|
|
|
Net Assets ($)
|
118,621,325
|
|
|
Composition of Net Assets ($):
|
||
|
Paid-in capital
|
54,943,180
|
|
|
Total distributable earnings (loss)
|
63,678,145
|
|
|
Net Assets ($)
|
118,621,325
|
|
|
Shares Outstanding
|
||
|
Shares outstanding no par value (unlimited shares authorized)
|
3,185,885
|
|
|
Net Asset Value Per Share ($)
|
37.23
|
|
|
Market Price Per Share ($)
|
37.23
|
|
|
|
|
Investment Income ($):
|
|
|
Income:
|
|
|
Cash dividends (net of $13,103 foreign taxes withheld at source):
|
|
|
Unaffiliated issuers
|
656,285
|
|
Affiliated issuers
|
81,288
|
|
Affiliated income net of rebates from securities lending-Note 2(c)
|
44,707
|
|
Total Income
|
782,280
|
|
Expenses:
|
|
|
Management fee-Note 3(a)
|
293,996
|
|
Total Expenses
|
293,996
|
|
Net Investment Income
|
488,284
|
|
Realized and Unrealized Gain (Loss) on Investments-Note 4 ($):
|
|
|
Net realized gain (loss) on investments
|
4,156,921
|
|
Net realized gain (loss) on in-kind redemptions
|
4,250,573
|
|
Net Realized Gain (Loss)
|
8,407,494
|
|
Net change in unrealized appreciation (depreciation) on investments
|
(5,250,396
)
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
3,157,098
|
|
Net Increase in Net Assets Resulting from Operations
|
3,645,382
|
|
|
Six Months Ended
April 30, 2026
(Unaudited)
|
Year Ended
October 31, 2025(a),(b),(c)
|
|
|
||
|
Operations ($):
|
||
|
Net investment income
|
488,284
|
577,682
|
|
Net realized gain (loss) on investments
|
8,407,494
|
43,925,422
|
|
Net change in unrealized appreciation (depreciation) on investments
|
(5,250,396)
|
(26,127,125)
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
3,645,382
|
18,375,979
|
|
Distributions ($):
|
||
|
Distributions to shareholders:
|
||
|
ETF shares
|
(489,732)
|
(507,021)
|
|
Class A
|
-
|
(26,913,854)
|
|
Class C
|
-
|
(786,825)
|
|
Class I
|
-
|
(7,152,860)
|
|
Total Distributions
|
(489,732)
|
(35,360,560)
|
|
Beneficial Interest Transactions ($):
|
||
|
Net proceeds from shares sold:
|
||
|
ETF shares
|
-
|
33,691,846
|
|
Class A
|
-
|
3,198,933
|
|
Class C
|
-
|
250
|
|
Class I
|
-
|
90,944,324
|
|
Net assets received in connection with reorganization(c)
|
-
|
111,903,401
|
|
Distributions reinvested:
|
||
|
Class A
|
-
|
23,036,046
|
|
Class C
|
-
|
784,813
|
|
Class I
|
-
|
6,982,587
|
|
Cost of shares redeemed:
|
||
|
ETF shares
|
(7,220,340)
|
(43,641,405)
|
|
Class A
|
-
|
(105,892,570)
|
|
Class C
|
-
|
(3,002,057)
|
|
Class I
|
-
|
(119,105,712)
|
|
Increase (Decrease) in Net Assets from Beneficial Interest Transactions
|
(7,220,340)
|
(1,099,544)
|
|
Total Increase (Decrease) in Net Assets
|
(4,064,690)
|
(18,084,125)
|
|
Net Assets ($):
|
||
|
Beginning of Period
|
122,686,015
|
140,770,140
|
|
End of Period
|
118,621,325
|
122,686,015
|
|
|
Six Months Ended
April 30, 2026
(Unaudited)
|
Year Ended
October 31, 2025(a),(b),(c)
|
|
|
||
|
Capital Share Transactions (Shares):
|
||
|
ETF shares
|
||
|
Shares sold
|
-
|
1,160,001
|
|
Shares issued in connection with reorganization(c)
|
-
|
3,645,886
|
|
Shares redeemed
|
(200,000)
|
(1,420,002)
|
|
Net Increase (Decrease) in Shares Outstanding
|
(200,000)
|
3,385,885
|
|
Class A(d),(e)
|
||
|
Shares sold
|
-
|
91,405
|
|
Shares issued for distributions reinvested
|
-
|
672,382
|
|
Shares redeemed
|
-
|
(3,361,607)
|
|
Net Increase (Decrease) in Shares Outstanding
|
-
|
(2,597,820)
|
|
Class C(d),(e)
|
||
|
Shares sold
|
-
|
7
|
|
Shares issued for distributions reinvested
|
-
|
26,323
|
|
Shares redeemed
|
-
|
(108,304)
|
|
Net Increase (Decrease) in Shares Outstanding
|
-
|
(81,974)
|
|
Class I(e)
|
||
|
Shares sold
|
-
|
2,915,257
|
|
Shares issued for distributions reinvested
|
-
|
202,801
|
|
Shares redeemed
|
-
|
(3,839,516)
|
|
Net Increase (Decrease) in Shares Outstanding
|
-
|
(721,458)
|
|
(a)
|
The fund commenced offering ETF shares after the close of business March 28, 2025. The amounts disclosed include those of BNY Mellon Tax Managed Growth
Fund (the "Predecessor Fund").
|
|
(b)
|
On March 14, 2025, the Predecessor Fund redesignated Class A and Class C shares into Class I shares.
|
|
(c)
|
As of the close of business on March 28, 2025, pursuant to an Agreement and Plan of Reorganization (the "Agreement") previously approved by the Predecessor
Fund's Board of Trustees (the "Predecessor Board"), all of the assets, subject to the liabilities, of the Predecessor Fund, a series of BNY Mellon Investment Funds IV,
Inc., were transferred to the fund in a tax free exchange for ETF shares. Shareholders of Class I shares of the Predecessor Fund received ETF shares of the fund.
|
|
(d)
|
During the period ended October 31, 2025, 540 Class C shares representing $18,591 were automatically converted to 474 Class A shares.
|
|
(e)
|
During the period ended October 31, 2025, 76,332 Class C shares representing $2,012,870 were converted to 64,702 Class I shares and 2,832,348 Class A shares
representing $87,547,888 were converted to 2,814,140 Class I shares.
|
|
|
Six Months Ended
April 30, 2026
(Unaudited)
|
Year Ended October 31,
|
||||
|
|
2025(a)
|
2024
|
2023
|
2022
|
2021
|
|
|
Per Share Data ($):
|
|
|
|
|
|
|
|
Net asset value, beginning of period
|
36.23
|
41.70
|
36.13
|
35.23
|
44.65
|
33.90
|
|
Investment Operations:
|
||||||
|
Net investment income(b)
|
.15
|
.23
|
.19
|
.24
|
.18
|
.14
|
|
Net realized and unrealized gain (loss) on
investments
|
1.00
|
4.74
|
8.12
|
3.43
|
(7.84
)
|
13.04
|
|
Total from Investment Operations
|
1.15
|
4.97
|
8.31
|
3.67
|
(7.66
)
|
13.18
|
|
Distributions:
|
||||||
|
Dividends from net investment income
|
(.15
)
|
(.24
)
|
(.21
)
|
(.23
)
|
(.04
)
|
(.15
)
|
|
Dividends from net realized gain on
investments
|
-
|
(10.20
)
|
(2.53
)
|
(2.54
)
|
(1.72
)
|
(2.28
)
|
|
Total Distributions
|
(.15
)
|
(10.44
)
|
(2.74
)
|
(2.77
)
|
(1.76
)
|
(2.43
)
|
|
Net asset value, end of period
|
37.23
|
36.23
|
41.70
|
36.13
|
35.23
|
44.65
|
|
Market value, end of period
|
37.23
|
36.26
|
N/A
|
N/A
|
N/A
|
N/A
|
|
Total Return (%)
|
3.21
(c)
|
15.21
|
24.12
|
10.95
|
(17.90
)
|
40.76
|
|
Market Price Total Return (%)
|
3.13
(c)
|
15.30
|
N/A
|
N/A
|
N/A
|
N/A
|
|
Ratios/Supplemental Data (%):
|
|
|
|
|
|
|
|
Ratio of total expenses to average net assets
|
.50
(d),(e)
|
.79
(e)
|
.97
|
.97
|
.96
|
.96
|
|
Ratio of net expenses to average net assets(f)
|
.50
(d),(e)
|
.66
(e),(g),(h)
|
.88
(g)
|
.95
|
.95
|
.95
|
|
Ratio of net investment income to average
net assets(f)
|
.83
(d),(e)
|
.46
(e),(g),(h)
|
.47
(g)
|
.67
|
.46
|
.36
|
|
Portfolio Turnover Rate(i)
|
5.97
(c)
|
14.05
|
14.92
|
1.73
|
7.55
|
4.27
|
|
Net Assets, end of period ($ x 1,000)
|
118,621
|
122,686
|
30,087
|
27,543
|
21,512
|
25,691
|
|
(a)
|
The fund commenced offering ETF shares after the close of business March 28, 2025. The amounts disclosed include those of the Predecessor Fund.
|
|
(b)
|
Based on average shares outstanding.
|
|
(c)
|
Not annualized.
|
|
(d)
|
Annualized.
|
|
(e)
|
Amount does not include the expenses of the underlying funds.
|
|
(f)
|
Amount inclusive of Directors' fees reimbursed by BNY Mellon Investment Adviser, Inc. For periods beginning on or after March 28, 2025, following the Fund's
reorganization into an ETF, the fee is paid by BNY Mellon ETF Investment Adviser, LLC.
|
|
(g)
|
Amount inclusive of reduction in expenses due to undertaking.
|
|
(h)
|
Amount inclusive of reduction in Distribution Plan fees.
|
|
(i)
|
Portfolio turnover rate does not include securities received or delivered from processing creations or redemptions.
|
|
|
Level 1 -
Unadjusted
Quoted Prices
|
Level 2- Other
Significant
Observable Inputs
|
Level 3-
Significant
Unobservable
Inputs
|
Total
|
|
Assets ($)
|
||||
|
Investments in Securities:†
|
||||
|
Equity Securities - Common Stocks
|
114,663,077
|
-
|
-
|
114,663,077
|
|
Investment Companies
|
4,141,484
|
-
|
-
|
4,141,484
|
|
|
118,804,561
|
-
|
-
|
118,804,561
|
|
†
|
See Schedule of Investments for additional detailed categorizations, if any.
|
|
Assets ($)
|
|
|
Gross amount of securities loaned, at
value, as disclosed in the Statement
of Assets and Liabilities
|
3,926,611
|
|
Collateral (received)/posted not offset
in the Statement of
Assets and Liabilities
|
(3,926,611
)†
|
|
Net amount
|
-
|
|
†
|
The value of the related collateral received by the fund exceeded the value of the securities loaned by the fund pursuant to the securities lending agreement. In addition,
the value of collateral may include pending sales that are also on loan. See Schedule of Investments for detailed information regarding collateral received for open
securities lending.
|
|
Item 7. Financial Statements and Financial Highlights for Open-End Management
Investment Companies
|
3
|
|
Schedule of Investments
|
3
|
|
Statement of Assets and Liabilities
|
7
|
|
Statement of Operations
|
8
|
|
Statement of Changes in Net Assets
|
9
|
|
Financial Highlights
|
10
|
|
Notes to Financial Statements
|
11
|
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management
Investment Companies
|
17
|
|
Item 9. Proxy Disclosures for Open-End Management Investment Companies
|
18
|
|
Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End
Management Investment Companies
|
19
|
|
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts
|
20
|
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Equity Securities - Common Stocks - 98.0%
|
|||||
|
Automobiles & Components - .9%
|
|||||
|
General Motors Co.
|
165,729
|
12,742,903
|
|||
|
Banks - 8.7%
|
|||||
|
Citigroup, Inc.
|
211,472
|
27,064,187
|
|||
|
Fifth Third Bancorp
|
481,147
|
24,423,022
|
|||
|
First Horizon Corp.
|
559,980
|
13,977,101
|
|||
|
JPMorgan Chase & Co.
|
134,037
|
41,984,409
|
|||
|
Truist Financial Corp.
|
248,231
|
12,783,896
|
|||
|
|
120,232,615
|
||||
|
Capital Goods - 10.3%
|
|||||
|
Carlisle Companies, Inc.
|
35,204
|
12,506,573
|
|||
|
Carrier Global Corp.
|
107,842
|
7,243,747
|
|||
|
Caterpillar, Inc.
|
17,500
|
15,576,925
|
|||
|
Deere & Co.
|
20,327
|
11,990,287
|
|||
|
Dover Corp.
|
47,810
|
10,824,662
|
|||
|
Emerson Electric Co.
|
68,722
|
9,651,318
|
|||
|
Ferguson Enterprises, Inc.
|
32,577
|
8,721,189
|
|||
|
Honeywell International, Inc.
|
73,435
|
15,739,323
|
|||
|
Hubbell, Inc.
|
26,522
|
13,477,685
|
|||
|
L3Harris Technologies, Inc.
|
30,294
|
9,710,742
|
|||
|
Regal Rexnord Corp.
|
48,957
|
10,527,224
|
|||
|
RTX Corp.
|
87,627
|
15,428,486
|
|||
|
|
141,398,161
|
||||
|
Commercial & Professional Services - .5%
|
|||||
|
Veralto Corp.
|
73,420
|
6,475,644
|
|||
|
Consumer Discretionary Distribution & Retail - 4.2%
|
|||||
|
Amazon.com, Inc.(a)
|
159,693
|
42,328,227
|
|||
|
Lowe's Companies, Inc.
|
64,038
|
15,291,634
|
|||
|
|
57,619,861
|
||||
|
Consumer Services - .5%
|
|||||
|
Las Vegas Sands Corp.
|
118,725
|
6,483,572
|
|||
|
Consumer Staples Distribution & Retail - .9%
|
|||||
|
Target Corp.
|
97,476
|
12,647,511
|
|||
|
Energy - 8.2%
|
|||||
|
ConocoPhillips
|
104,351
|
13,125,269
|
|||
|
Diamondback Energy, Inc.
|
59,985
|
12,334,715
|
|||
|
EQT Corp.
|
139,260
|
8,366,741
|
|||
|
Marathon Petroleum Corp.
|
58,390
|
14,497,653
|
|||
|
Occidental Petroleum Corp.
|
194,789
|
11,800,318
|
|||
|
Phillips 66
|
101,733
|
18,225,467
|
|||
|
SLB Ltd.
|
599,987
|
34,127,260
|
|||
|
|
112,477,423
|
||||
|
Equity Real Estate Investment Trusts - 1.2%
|
|||||
|
Weyerhaeuser Co.(b),(c)
|
683,055
|
16,748,509
|
|||
|
Financial Services - 8.6%
|
|||||
|
Berkshire Hathaway, Inc., Cl. B(a)
|
77,701
|
36,799,194
|
|||
|
Capital One Financial Corp.
|
56,972
|
10,898,744
|
|||
|
CME Group, Inc.
|
35,832
|
10,313,166
|
|||
|
Morgan Stanley
|
117,267
|
22,349,917
|
|||
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Equity Securities - Common Stocks - 98.0% (continued)
|
|||||
|
Financial Services - 8.6% (continued)
|
|||||
|
The Charles Schwab Corp.
|
79,494
|
7,284,830
|
|||
|
The Goldman Sachs Group, Inc.
|
19,253
|
17,785,344
|
|||
|
Voya Financial, Inc.
|
159,557
|
13,077,292
|
|||
|
|
118,508,487
|
||||
|
Health Care Equipment & Services - 6.9%
|
|||||
|
Alcon AG(c)
|
109,138
|
8,171,162
|
|||
|
Edwards Lifesciences Corp.(a)
|
133,984
|
11,187,664
|
|||
|
Elevance Health, Inc.
|
55,635
|
20,942,126
|
|||
|
Medtronic PLC
|
137,335
|
11,120,015
|
|||
|
UnitedHealth Group, Inc.
|
116,487
|
43,156,104
|
|||
|
|
94,577,071
|
||||
|
Household & Personal Products - 2.8%
|
|||||
|
Colgate-Palmolive Co.
|
333,311
|
28,451,427
|
|||
|
The Estee Lauder Companies, Inc., Cl. A
|
130,964
|
10,046,248
|
|||
|
|
38,497,675
|
||||
|
Insurance - 5.8%
|
|||||
|
American International Group, Inc.
|
193,411
|
14,467,143
|
|||
|
Aon PLC, Cl. A
|
56,664
|
17,659,336
|
|||
|
Assurant, Inc.
|
92,638
|
21,887,580
|
|||
|
Chubb Ltd.
|
53,284
|
17,423,868
|
|||
|
The Hartford Insurance Group, Inc.
|
58,087
|
7,946,882
|
|||
|
|
79,384,809
|
||||
|
Materials - 5.4%
|
|||||
|
CRH PLC
|
133,036
|
15,754,123
|
|||
|
Freeport-McMoRan, Inc.
|
225,319
|
13,018,932
|
|||
|
Newmont Corp.
|
226,205
|
25,129,114
|
|||
|
Packaging Corp. of America
|
94,232
|
20,113,820
|
|||
|
|
74,015,989
|
||||
|
Media & Entertainment - 5.9%
|
|||||
|
Alphabet, Inc., Cl. A
|
85,497
|
32,899,246
|
|||
|
Meta Platforms, Inc., Cl. A
|
16,674
|
10,202,987
|
|||
|
Omnicom Group, Inc.
|
308,123
|
23,639,196
|
|||
|
The Walt Disney Company
|
138,585
|
14,378,194
|
|||
|
|
81,119,623
|
||||
|
Pharmaceuticals, Biotechnology & Life Sciences - 7.2%
|
|||||
|
Bristol-Myers Squibb Co.
|
227,831
|
13,804,280
|
|||
|
Gilead Sciences, Inc.
|
79,300
|
10,375,612
|
|||
|
Jazz Pharmaceuticals PLC(a)
|
34,546
|
7,013,529
|
|||
|
Johnson & Johnson
|
157,321
|
36,160,232
|
|||
|
Pfizer, Inc.
|
462,884
|
12,359,003
|
|||
|
Thermo Fisher Scientific, Inc.
|
41,188
|
19,727,404
|
|||
|
|
99,440,060
|
||||
|
Semiconductors & Semiconductor Equipment - 7.9%
|
|||||
|
Advanced Micro Devices, Inc.(a)
|
37,529
|
13,303,655
|
|||
|
Applied Materials, Inc.
|
74,755
|
29,490,100
|
|||
|
Intel Corp.(a)
|
183,728
|
17,358,622
|
|||
|
Marvell Technology, Inc.
|
43,646
|
7,208,137
|
|||
|
Texas Instruments, Inc.
|
145,029
|
40,764,751
|
|||
|
|
108,125,265
|
||||
|
Software & Services - 2.5%
|
|||||
|
Akamai Technologies, Inc.(a)
|
150,351
|
15,483,146
|
|||
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Equity Securities - Common Stocks - 98.0% (continued)
|
|||||
|
Software & Services - 2.5% (continued)
|
|||||
|
Dolby Laboratories, Inc., Cl. A
|
148,782
|
9,542,878
|
|||
|
International Business Machines Corp.
|
38,484
|
8,889,034
|
|||
|
|
33,915,058
|
||||
|
Technology Hardware & Equipment - 3.6%
|
|||||
|
Cisco Systems, Inc.
|
388,251
|
35,524,967
|
|||
|
Seagate Technology Holdings PLC
|
11,077
|
7,461,910
|
|||
|
Western Digital Corp.(c)
|
15,358
|
6,673,358
|
|||
|
|
49,660,235
|
||||
|
Telecommunication Services - 1.0%
|
|||||
|
AT&T, Inc.
|
534,950
|
13,978,244
|
|||
|
Transportation - 3.6%
|
|||||
|
CSX Corp.
|
393,965
|
17,897,830
|
|||
|
Delta Air Lines, Inc.
|
262,870
|
17,872,531
|
|||
|
FedEx Corp.
|
34,578
|
13,945,653
|
|||
|
|
49,716,014
|
||||
|
Utilities - 1.4%
|
|||||
|
Constellation Energy Corp.
|
33,780
|
10,573,140
|
|||
|
NRG Energy, Inc.
|
57,608
|
8,962,653
|
|||
|
|
19,535,793
|
||||
|
Total Equity Securities - Common Stocks
(cost $1,204,554,693)
|
1,347,300,522
|
||||
|
|
|
1-Day
Yield (%)
|
|
|
|
|
Investment Companies - 2.0%
|
|||||
|
Registered Investment Companies - 2.0%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(d)
(cost $27,147,890)
|
3.61
|
27,147,890
|
27,147,890
|
||
|
Investment of Cash Collateral for Securities Loaned - .1%
|
|||||
|
Registered Investment Companies - .1%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares(d)
(cost $1,319,407)
|
3.61
|
1,319,407
|
1,319,407
|
||
|
Total Investments (cost $1,233,021,990)
|
|
100.1%
|
1,375,767,819
|
||
|
Liabilities, Less Cash and Receivables
|
|
(.1%)
|
(855,021)
|
||
|
Net Assets
|
100.0%
|
1,374,912,798
|
|||
|
(a)
|
Non-income producing security.
|
|
(b)
|
Investment in real estate investment trust within the United States.
|
|
(c)
|
Security, or portion thereof, on loan. At April 30, 2026, the value of the fund's securities on loan was $4,583,198 and the value of the collateral was
$4,614,311, consisting of cash collateral of $1,319,407 and U.S. Government & Agency securities valued at $3,294,904. In addition, the value of collateral
may include pending sales that are also on loan.
|
|
(d)
|
Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's
prospectus.
|
|
Affiliated Issuers
|
|||||
|
Description
|
Value ($)
10/31/2025
|
Purchases ($)†
|
Sales ($)
|
Value ($)
4/30/2026
|
Dividends/
Distributions ($)
|
|
Registered Investment Companies - 2.0%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market
Fund, Institutional Shares - 2.0%
|
4,766,105
|
57,336,321
|
(34,954,536)
|
27,147,890
|
195,239
|
|
Affiliated Issuers (continued)
|
|||||
|
Description
|
Value ($)
10/31/2025
|
Purchases ($)†
|
Sales ($)
|
Value ($)
4/30/2026
|
Dividends/
Distributions ($)
|
|
Investment of Cash Collateral for Securities Loaned - .1%
|
|||||
|
Dreyfus Institutional Preferred Government Money Market
Fund, Institutional Shares - .1%
|
-
|
2,933,530
|
(1,614,123)
|
1,319,407
|
1,823††
|
|
Total - 2.1%
|
4,766,105
|
60,269,851
|
(36,568,659)
|
28,467,297
|
197,062
|
|
†
|
Includes reinvested dividends/distributions.
|
|
††
|
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and
other payments to and from borrowers of securities.
|
|
|
Cost
|
Value
|
|
Assets ($):
|
||
|
Investments in securities-See Schedule of Investments
(including securities on loan, valued at $4,583,198)-Note 2(c):
|
||
|
Unaffiliated issuers
|
1,204,554,693
|
1,347,300,522
|
|
Affiliated issuers
|
28,467,297
|
28,467,297
|
|
Receivable for investment securities sold
|
12,205,651
|
|
|
Dividends and securities lending income receivable
|
709,718
|
|
|
Receivable for shares of Beneficial Interest subscribed
|
256,078
|
|
|
Tax reclaim receivable-Note 2(b)
|
7,022
|
|
|
|
1,388,946,288
|
|
|
Liabilities ($):
|
||
|
Due to BNY Mellon ETF Investment Adviser, LLC-Note 3(b)
|
587,002
|
|
|
Payable for investment securities purchased
|
12,127,081
|
|
|
Liability for securities on loan-Note 2(c)
|
1,319,407
|
|
|
|
14,033,490
|
|
|
Net Assets ($)
|
1,374,912,798
|
|
|
Composition of Net Assets ($):
|
||
|
Paid-in capital
|
1,209,376,013
|
|
|
Total distributable earnings (loss)
|
165,536,785
|
|
|
Net Assets ($)
|
1,374,912,798
|
|
|
Shares Outstanding
|
||
|
Shares outstanding no par value (unlimited shares authorized)
|
43,084,000
|
|
|
Net Asset Value Per Share ($)
|
31.91
|
|
|
Market Price Per Share ($)
|
31.93
|
|
|
|
|
Investment Income ($):
|
|
|
Income:
|
|
|
Cash dividends (net of $353 foreign taxes withheld at source):
|
|
|
Unaffiliated issuers
|
7,634,354
|
|
Affiliated issuers
|
195,239
|
|
Affiliated income net of rebates from securities lending-Note 2(c)
|
1,823
|
|
Total Income
|
7,831,416
|
|
Expenses:
|
|
|
Management fee-Note 3(a)
|
2,577,840
|
|
Total Expenses
|
2,577,840
|
|
Net Investment Income
|
5,253,576
|
|
Realized and Unrealized Gain (Loss) on Investments-Note 4 ($):
|
|
|
Net realized gain (loss) on investments
|
22,556,629
|
|
Net realized gain (loss) on in-kind redemptions
|
1,953,495
|
|
Net Realized Gain (Loss)
|
24,510,124
|
|
Net change in unrealized appreciation (depreciation) on investments
|
97,132,875
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
121,642,999
|
|
Net Increase in Net Assets Resulting from Operations
|
126,896,575
|
|
|
Six Months Ended
April 30, 2026
(Unaudited)
|
Period Ended
October 31, 2025(a)
|
|
|
||
|
Operations ($):
|
||
|
Net investment income
|
5,253,576
|
2,849,161
|
|
Net realized gain (loss) on investments
|
24,510,124
|
(3,682,785)
|
|
Net change in unrealized appreciation (depreciation) on investments
|
97,132,875
|
45,612,954
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
126,896,575
|
44,779,330
|
|
Distributions ($):
|
||
|
Distributions to shareholders
|
(4,522,003)
|
(36,764)
|
|
Beneficial Interest Transactions ($):
|
||
|
Net proceeds from shares sold
|
702,499,554
|
528,333,177
|
|
Cost of shares redeemed
|
(9,012,437)
|
(14,124,634)
|
|
Increase (Decrease) in Net Assets from Beneficial Interest Transactions
|
693,487,117
|
514,208,543
|
|
Total Increase (Decrease) in Net Assets
|
815,861,689
|
558,951,109
|
|
Net Assets ($):
|
||
|
Beginning of Period
|
559,051,109
|
100,000
|
|
End of Period
|
1,374,912,798
|
559,051,109
|
|
Capital Share Transactions (Shares):
|
||
|
Initial shares
|
-
|
4,000
|
|
Shares sold
|
23,400,000
|
20,540,000
|
|
Shares redeemed
|
(300,000)
|
(560,000)
|
|
Net Increase (Decrease) in Shares Outstanding
|
23,100,000
|
19,984,000
|
|
(a)
|
From November 4, 2024 (commencement of operations) to October 31, 2025.
|
|
|
Six Months Ended
April 30, 2026
(Unaudited)
|
Period Ended
October 31, 2025(a)
|
|
Per Share Data ($):
|
|
|
|
Net asset value, beginning of period
|
27.97
|
25.00
|
|
Investment Operations:
|
||
|
Net investment income(b)
|
.18
|
.31
|
|
Net realized and unrealized gain (loss) on investments
|
3.94
|
2.73
|
|
Total from Investment Operations
|
4.12
|
3.04
|
|
Distributions:
|
||
|
Dividends from net investment income
|
(.18
)
|
(.07
)
|
|
Net asset value, end of period
|
31.91
|
27.97
|
|
Market value, end of period
|
31.93
|
28.00
|
|
Total Return (%)(c)
|
14.77
|
12.20
(d)
|
|
Market Price Total Return (%)(c)
|
14.73
|
12.31
(d)
|
|
Ratios/Supplemental Data (%):
|
|
|
|
Ratio of total expenses to average net assets(e),(f)
|
.60
|
.60
|
|
Ratio of net investment income to average net assets(e),(f)
|
1.22
|
1.19
|
|
Portfolio Turnover Rate(c),(g)
|
58.99
|
104.28
|
|
Net Assets, end of period ($ x 1,000)
|
1,374,913
|
559,051
|
|
(a)
|
From November 4, 2024 (commencement of operations) to October 31, 2025.
|
|
(b)
|
Based on average shares outstanding.
|
|
(c)
|
Not annualized.
|
|
(d)
|
The net asset value total return and the market price total return is calculated from fund inception. The inception date is the first date the fund was available on
NYSE Arca, Inc.
|
|
(e)
|
Annualized.
|
|
(f)
|
Amount does not include the expenses of the underlying funds.
|
|
(g)
|
Portfolio turnover rate does not include securities received or delivered from processing creations or redemptions.
|
|
|
Level 1 -
Unadjusted
Quoted Prices
|
Level 2- Other
Significant
Observable Inputs
|
Level 3-
Significant
Unobservable
Inputs
|
Total
|
|
Assets ($)
|
||||
|
Investments in Securities:†
|
||||
|
Equity Securities - Common Stocks
|
1,347,300,522
|
-
|
-
|
1,347,300,522
|
|
Investment Companies
|
28,467,297
|
-
|
-
|
28,467,297
|
|
|
1,375,767,819
|
-
|
-
|
1,375,767,819
|
|
†
|
See Schedule of Investments for additional detailed categorizations, if any.
|
|
Assets ($)
|
|
|
Gross amount of securities loaned, at
value, as disclosed in the Statement
of Assets and Liabilities
|
4,583,198
|
|
Collateral (received)/posted not offset
in the Statement of
Assets and Liabilities
|
(4,583,198
)†
|
|
Net amount
|
-
|
|
†
|
The value of the related collateral received by the fund exceeded the value of the securities loaned by the fund pursuant to the securities lending agreement. In addition,
the value of collateral may include pending sales that are also on loan. See Schedule of Investments for detailed information regarding collateral received for open
securities lending.
|
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the Registrant's Board of Trustees, where those changes were implemented after the Registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.
Item 16. Controls and Procedures.
| (a) | The Registrant's principal executive and principal financial officers, or persons performing similar functions, have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the 1940 Act (17 CFR 270.30a-3(c))) are effective, as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)). |
| (b) | There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d))) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting. |
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not Applicable.
Item 19. Exhibits.
| (a)(1) | Not applicable. |
| (a)(2) | Not applicable. |
| (a)(3) | Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto. |
| (a)(4) | Not applicable. |
| (a)(5) | Not applicable. |
| (b) | Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) BNY Mellon ETF Trust II
By (Signature and Title) * /s/ David J. DiPetrillo
David J. DiPetrillo, President
(Principal Executive Officer)
Date 06/22/2026
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title) * /s/ David J. DiPetrillo
David J. DiPetrillo, President
(Principal Executive Officer)
Date 06/22/2026
By (Signature and Title) * /s/ James Windels
James Windels, Treasurer
(Principal Financial and Accounting Officer)
Date 06/22/2026
* Print the name and title of each signing officer under his or her signature.